What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Gene
His scientific interests lie mostly in Internal medicine, Endocrinology, Neuroscience, Alzheimer's disease and Arachidonic acid.
His Internal medicine research is multidisciplinary, incorporating perspectives in Positron emission tomography, Biochemistry, Human brain and Cardiology.
Stanley I. Rapoport works in the field of Endocrinology, namely Central nervous system.
His Neuroscience research includes themes of Synaptic plasticity and Cerebral blood flow.
His Alzheimer's disease research incorporates elements of Central nervous system disease, Degenerative disease and Dementia, Cognitive decline.
His research in Arachidonic acid intersects with topics in Unsaturated fatty acid, Cyclooxygenase and Metabolism.
His most cited work include:
- Blood-Brain Barrier in Physiology and Medicine (880 citations)
- Dissociation of object and spatial visual processing pathways in human extrastriate cortex (817 citations)
- Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. (730 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Endocrinology, Arachidonic acid, Biochemistry and Neuroscience are his primary areas of study.
Many of his studies involve connections with topics such as Positron emission tomography and Internal medicine.
His Positron emission tomography research integrates issues from Dementia, Disease and Cardiology.
Stanley I. Rapoport has included themes like Docosahexaenoic acid, Polyunsaturated fatty acid, Fatty acid and Phospholipid in his Endocrinology study.
Stanley I. Rapoport interconnects Lithium, Phospholipase A2, Neuroinflammation, Cyclooxygenase and Pharmacology in the investigation of issues within Arachidonic acid.
His Alzheimer's disease research includes elements of Central nervous system disease and Degenerative disease.
He most often published in these fields:
- Internal medicine (51.36%)
- Endocrinology (46.34%)
- Arachidonic acid (20.19%)
What were the highlights of his more recent work (between 2006-2021)?
- Internal medicine (51.36%)
- Endocrinology (46.34%)
- Arachidonic acid (20.19%)
In recent papers he was focusing on the following fields of study:
Stanley I. Rapoport spends much of his time researching Internal medicine, Endocrinology, Arachidonic acid, Docosahexaenoic acid and Polyunsaturated fatty acid.
His Internal medicine study combines topics in areas such as Human brain, Bipolar disorder and In vivo.
As a member of one scientific family, he mostly works in the field of Endocrinology, focusing on Eicosanoid and, on occasion, Serotonin.
His research integrates issues of Unsaturated fatty acid, Phospholipase A2, Neuroinflammation, Cyclooxygenase and Pharmacology in his study of Arachidonic acid.
The study incorporates disciplines such as Eicosapentaenoic acid and Phospholipid in addition to Docosahexaenoic acid.
His work deals with themes such as Weaning, Lipid metabolism, Linolenic acid and Homeostasis, which intersect with Polyunsaturated fatty acid.
Between 2006 and 2021, his most popular works were:
- Brain fuel metabolism, aging, and Alzheimer’s disease (355 citations)
- Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. (317 citations)
- n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. (248 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Gene
Stanley I. Rapoport focuses on Internal medicine, Endocrinology, Arachidonic acid, Docosahexaenoic acid and Polyunsaturated fatty acid.
The various areas that Stanley I. Rapoport examines in his Internal medicine study include Bipolar disorder and CREB.
His study in Endocrinology is interdisciplinary in nature, drawing from both Linoleic acid, Downregulation and upregulation, Neuroprotection, Alzheimer's disease and In vivo.
The Arachidonic acid study combines topics in areas such as Unsaturated fatty acid, Phospholipase A2, Pharmacology and Human brain.
His Docosahexaenoic acid study combines topics from a wide range of disciplines, such as Eicosapentaenoic acid and Phospholipid.
His Polyunsaturated fatty acid research is multidisciplinary, incorporating elements of Schizophrenia, Psychiatry, Weaning, Linolenic acid and Lipid metabolism.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
